1095545-16-6

Basic information

• Product Name: 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL
• Synonyms: 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL;3-(3-CHLORO-PHENYL)PYRROLIDINE HYDROCHLORIDE
• CAS NO: 1095545-16-6
• Molecular Formula: C10H13Cl2N
• Molecular Weight: 218.12
• Mol File: 1095545-16-6.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL(1095545-16-6)
• EPA Substance Registry System: 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL(1095545-16-6)

Safety Data

• Hazardous Substances Data: 1095545-16-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-(3-CHLORO-PHENYL) PYRROLIDINE HCL is used as a key intermediate for the synthesis of various bioactive molecules and drug candidates. Its unique chemical structure allows it to be incorporated into a wide range of therapeutic agents, enhancing their efficacy and selectivity.
Used in Research:
In the research field, 3-(3-CHLORO-PHENYL) PYRROLIDINE HCL serves as a valuable tool for studying the structure-activity relationships of different compounds. Its versatile chemical properties enable researchers to explore its potential applications in various biological systems and disease models.
Used in Neurological and Psychiatric Disorders Treatment:
3-(3-CHLORO-PHENYL) PYRROLIDINE HCL has been studied for its potential therapeutic applications in the treatment of neurological and psychiatric disorders. Its ability to modulate specific neurotransmitter systems and receptor interactions makes it a promising candidate for the development of novel treatments for conditions such as depression, anxiety, and neurodegenerative diseases.
Used in Analgesic and Anti-inflammatory Medications:
3-(3-CHLORO-PHENYL) PYRROLIDINE HCL has also been investigated for its potential use in the development of analgesic and anti-inflammatory medications. Its capacity to modulate pain and inflammation pathways could lead to the creation of new drugs with improved efficacy and reduced side effects compared to existing therapies.